Compare TKLF & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKLF | TNON |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 12.8M |
| IPO Year | 2022 | 2022 |
| Metric | TKLF | TNON |
|---|---|---|
| Price | $2.50 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 10.7K | ★ 107.4K |
| Earning Date | 12-19-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $210,119,238.00 | $3,233,000.00 |
| Revenue This Year | N/A | $19.56 |
| Revenue Next Year | N/A | $71.06 |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | ★ 7.38 | N/A |
| 52 Week Low | $2.10 | $0.85 |
| 52 Week High | $4.32 | $5.85 |
| Indicator | TKLF | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 46.15 |
| Support Level | $2.35 | $1.11 |
| Resistance Level | $2.63 | $1.17 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 59.70 | 46.27 |
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.